|
End-of-day quote
Mexican S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 1,000.00 MXN | -0.60% |
|
-.--% | +30.12% |
| 03:23am | Bayer clears hurdle to expand Kerendia indication in the US |  |
| 02:55am | Bayer's Supplemental Drug Application for Chronic Kidney Disease Wins US FDA Acceptance | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Bayer AG(BAYN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Bayer AG(BAYN)
EBIT
Dividend / Share (DPS)
Data source:
Bayer AG(BAYN)
Cash or Net Debt
- Stock Market
- Stocks
- BAYN Stock
- BAYN N Stock
- Consensus Bayer AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
